Eurax

Manufacturer
Ranbaxy Laboratories Inc. | DPT Laboratories, Ltd
Effective date
2015-01-30
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 01:33:08

Label at a glance#

ProductEurax
Active ingredientCROTAMITON
Label structure12 sections

Indications and uses

For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.

Dosage and administration

In Scabies: Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Clothing and bed linen should be changed the next morning. A cleansing bath should be taken 48 hours after the last application. In Pruritus: Massage gently into affected areas until medication is completely absorbed. Repeat as ne...

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Eurax (crotamiton, USP) is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. Eurax provides 10% (w/w) of the synthetic, crotamiton, USP, in a vanishing-cream or emollient-lotion base containing: carbomer-934, cetyl alcohol, diazolidinylurea, dimethicone, fragrance, laureth-23, magnesium aluminum silicate, magnesium nitrate, methylchloroisothiazolinone, methylisothiazolinone, petrolatum, propylene glycol, sodium hydroxide, steareth-2, and water. In addition, the cream contains glyceryl stearate.

Crotamiton is N-ethyl-N-(o-methylphenyl)-2-butenamide and its structural formula is:

structurenew
structurenew

Crotamiton, USP is a colorless to slightly yellowish oil, having a faint amine-like odor. It is miscible with alcohol and with methanol. Crotamiton is a mixture of the cis and trans isomers. Its molecular weight is 203.28.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Eurax has scabicidal and antipruritic actions. The mechanisms of these actions are not known. The pharmacokinetics of crotamiton and its degree of systemic absorption following topical application have not been determined.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Eurax should not be applied topically to patients who develop a sensitivity or are allergic to it or who manifest a primary irritation response to topical medications.

WARNINGS

WARNINGS SECTION

If severe irritation or sensitization develops, treatment with this product should be discontinued and appropriate therapy instituted.

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

Eurax should not be applied in the eyes or mouth because it may cause irritation. It should not be applied to acutely inflamed skin or raw or weeping surfaces until the acute inflammation has subsided.

Information for Patients

INFORMATION FOR PATIENTS SECTION

See DIRECTIONS FOR PATIENTS WITH SCABIES

Drug Interactions

DRUG INTERACTIONS SECTION

None known.

Carcinogenesis and Mutagenesis and Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term carcinogenicity studies in animals have not been conducted.

Pregnancy (Category C)

PREGNANCY SECTION

Animal reproduction studies have not been conducted with Eurax. It is also not known whether Eurax can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. Eurax should be given to a pregnant woman only if clearly needed.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness in pediatric patients have not been established.

Geriatric Use

GERIATRIC USE SECTION

Clinical studies with Eurax (crotamiton, USP) Lotion/Cream did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients.

OVERDOSAGE

OVERDOSAGE SECTION

There is no specific information on the effect of overtreatment with repeated topical applications in humans. A death was reported but cause was not confirmed.

Accidental oral ingestion may be accompanied by burning sensation in the mouth, irritation of the buccal, esophageal and gastric mucosa, nausea, vomiting, abdominal pain.

If accidental ingestion occurs, call your Poison Control Center.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

In Scabies: Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Clothing and bed linen should be changed the next morning. A cleansing bath should be taken 48 hours after the last application.

In Pruritus: Massage gently into affected areas until medication is completely absorbed. Repeat as needed.

LOTION: Shake well before using.

DIRECTIONS FOR PATIENTS WITH SCABIES:

INSTRUCTIONS FOR USE SECTION

  • Take a routine bath or shower. Thoroughly massage Eurax cream or lotion into the skin from the chin to the toes including folds and creases.
  • Put Eurax cream or lotion under fingernails after trimming the fingernails short, because scabies are very likely to remain there. A toothbrush can be used to apply the Eurax cream or lotion under the fingernails. Immediately after use, the toothbrush should be wrapped in paper and thrown away. Use of the same brush in the mouth could lead to poisoning.
  • A second application is advisable 24 hours later.
  • A 60 gram tube or bottle is sufficient for two applications.
  • Clothing and bed linen should be changed the next day. Contaminated clothing and bed linen may be dry-cleaned, or washed in the hot cycle of the washing machine.
  • A cleansing bath should be taken 48 hours after the last application

HOW SUPPLIED

HOW SUPPLIED SECTION

Eurax® (crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream with a perfumed characteristic odor and supplied as:

60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)

Eurax® (crotamiton, USP) Lotion, 10% is a white to yellowish-white lotion having a characteristic perfumed odor and supplied as:

60 g (2 oz.) bottle NDC 10631-092-60 (NSN 6505-01-153-4423)

454 g (16 oz.) bottle NDC 10631-092-16

SHAKE WELL before using.

Store at room temperature.

Keep out of reach of children.

To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

RANBAXY

Jacksonville, FL 32257 USA

129845

September 2012

Eurax Cream

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Eurax Cream 60 g Tube
Eurax Cream 60 g Tube
Eurax Cream 60 g Tube
Eurax Cream 60 g Tube

Eurax Cream 60 g Tube

Eurax Cream 60 g Tube

Eurax Cream 60 g Carton

Eurax Lotion

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

lotiontubelabel
lotiontubelabel

Eurax Lotion 60 g (2 oz.) label

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
10631-091-60GM - Gram10631-0918d49c344-339d-479c-a805-4c763fead73312012-07-24
10631-092-16GM - Gram10631-0923514378a-13af-44c7-8df1-f83ebdcd7ce612012-07-24
10631-092-60GM - Gram10631-0928397acbc-d5d6-49ee-b4c3-6b150b90645412012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CROTAMITONACTIVE INGREDIENTD6S4O4XD0H3
CROTAMITONACTIVE MOIETYD6S4O4XD0H3
CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)INACTIVE INGREDIENTZ135WT92083
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCN3
DIAZOLIDINYL UREAINACTIVE INGREDIENTH5RIZ3MPW43
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O3
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE43
LAURETH-23INACTIVE INGREDIENTN72LMW566G3
MAGNESIUM ALUMINUM SILICATEINACTIVE INGREDIENT6M3P64V0NC3
MAGNESIUM NITRATEINACTIVE INGREDIENT77CBG3UN783
METHYLCHLOROISOTHIAZOLINONEINACTIVE INGREDIENTDEL7T5QRPN3
METHYLISOTHIAZOLINONEINACTIVE INGREDIENT229D0E1QFA3
PETROLATUMINACTIVE INGREDIENT4T6H12BN9U3
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V33
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I3
STEARETH-2INACTIVE INGREDIENTV56DFE46J53
WATERINACTIVE INGREDIENT059QF0KO0R3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10631-09110631-091-60
10631-09210631-092-60, 10631-092-16

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 32 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 357 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNEMULSION / TOPICALNAExact identifier — unii candidate
20 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UCAPSULE / VAGINALNAExact identifier — unii candidate
18 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRALESIONALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / SUBCUTANEOUSNAExact identifier — unii candidate
174 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED, EXTENDED RELEASE / ORAL19 mgExact identifier — unii candidate
81 equally ranked IID candidates
LAURETH-23LAURETH-23N72LMW566GLOTION / TOPICAL0.5 %w/wExact identifier — unii candidate
5 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / RECTALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAVENOUS16624 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED / ORAL25 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3DROPS / ORAL200 mg/1mlExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / INTRADERMALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET, CHEWABLE / ORAL1 mgExact identifier — unii candidate
21 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / URETERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / PARENTERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / PARENTERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IGEL / VAGINAL20 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INFILTRATIONADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / RECTAL3315 mgExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4SUSPENSION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
21 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ILOTION / TOPICAL21 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRAMUSCULAR176 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / INTRASYNOVIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRAVENOUS78 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRAMUSCULAR78 mgExact identifier — unii candidate
174 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNLOTION / TOPICAL1140 mgExact identifier — unii candidate
20 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / PARENTERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY / NASAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / VAGINAL1225 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / EPIDURALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
LAURETH-23LAURETH-23N72LMW566GEMULSION / TOPICAL0.45 %w/wExact identifier — unii candidate
5 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / VAGINAL750 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRADISCALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / RECTALNAExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRAMUSCULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / INTRAVENOUS4000 mgExact identifier — unii candidate
81 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNAEROSOL, FOAM / VAGINAL0.75 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208LOTION / TOPICAL21 mgExact identifier — unii candidate
14 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNTABLET, COATED / ORAL0.25 mgExact identifier — unii candidate
20 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICAPSULE / ORAL60 mgExact identifier — unii candidate
174 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / ORAL27120 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / TOPICAL39 mgExact identifier — unii candidate
174 equally ranked IID candidates
LAURETH-23LAURETH-23N72LMW566GAEROSOL / TOPICAL0.45 %w/wExact identifier — unii candidate
5 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION/ DROPS / OPHTHALMICADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPONGE / TOPICAL40 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
DIAZOLIDINYL UREADIAZOLIDINYL UREAH5RIZ3MPW4OINTMENT / TOPICAL0.1 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / TOPICAL1800 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, DELAYED RELEASE / ORAL36 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / SUBCUTANEOUS1 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAMUSCULAR7459 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICAPSULE, COATED / ORAL0.08 mgExact identifier — unii candidate
174 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT, AUGMENTED / TOPICAL5850 mgExact identifier — unii candidate
18 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT / AURICULAR (OTIC)NAExact identifier — unii candidate
18 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATEMAGNESIUM ALUMINUM SILICATE6M3P64V0NCPASTE, DENTIFRICE / DENTAL0.4 %w/wExact identifier — unii candidate
17 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRADERMALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / PARENTERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / INTRALESIONALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 2 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N006927-001EURAXCROTAMITON10%CREAM / TOPICALRLD, RS, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N006927-001EURAX10%CREAM / TOPICALRLD, RS, Approved before 1982d4dbc9d85df4…
2026-10-15 13:18:302026-09N006927-001EURAX10%CREAM / TOPICALRLD, RS, Approved before 1982c2088c7a36db…
2026-09-14 22:38:342026-08N006927-001EURAX10%CREAM / TOPICALRLD, RS, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07N006927-001EURAX10%CREAM / TOPICALRLD, RS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N006927-001EURAX10%CREAM / TOPICALRLD, RS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N006927-001EURAX10%CREAM / TOPICALRLD, Approved before 19823bdfa0b2c4d7…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N009112-003EURAXCROTAMITON10%LOTION / TOPICALRLD, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N009112-003EURAX10%LOTION / TOPICALRLD, Approved before 1982d4dbc9d85df4…
2026-10-15 13:18:302026-09N009112-003EURAX10%LOTION / TOPICALRLD, Approved before 1982c2088c7a36db…
2026-09-14 22:38:342026-08N009112-003EURAX10%LOTION / TOPICALRLD, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07N009112-003EURAX10%LOTION / TOPICALRLD, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N009112-003EURAX10%LOTION / TOPICALATRLD, RS, Approved before 19823bdfa0b2c4d7…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02N009112-003AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N009112-003AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08N009112-003AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N009112-003AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N009112-003AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N009112-003AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N009112-003AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N009112-003AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N009112-003AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N009112-003AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N009112-003AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N009112-003AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N009112-003AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N009112-003AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N009112-003AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N009112-003AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N009112-003AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N009112-003AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N009112-003AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N009112-003AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N009112-003AT187673890dc5c…
2021-03-12 10:30 UTC2021-03N009112-003AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N009112-003AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N009112-003AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N009112-003AT13f01610625f2…
2019-09-15 20:21 UTC2019-09N009112-003AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07N009112-003AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N009112-003AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N009112-003AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N009112-003AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N009112-003AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N009112-003AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N009112-003AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N009112-003AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05N009112-003AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01N009112-003AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N009112-003AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N009112-003AT1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N009112-003AT1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N009112-003AT1cb3db0bc1861…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f87f6e5f-30bc-4658-b7ed-7c2a823522a056465446-7f78-4ad1-acb3-08a4d60e57152015-01-30Warnings, Adverse reactionsExact identifier
spl id: f87f6e5f-30bc-4658-b7ed-7c2a823522a0
spl set id: 56465446-7f78-4ad1-acb3-08a4d60e5715

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.